 NEW YORK, Nov. 16, 2020 GLOBE NEWSWIRE -- Predictive Oncology NASDAQ: POAI, a knowledge-driven company focused on applying artificial intelligence AI to personalized medicine and drug discovery, today reported financial results for the quarter ended September 30, 2020 and provided a business update. 